Jaguar Animal Health, Inc. (NASDAQ:JAGX – Get Free Report) shares crossed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $2.65 and traded as low as $0.97. Jaguar Animal Health shares last traded at $1.03, with a volume of 228,810 shares trading hands.
Analyst Ratings Changes
Several research firms have issued reports on JAGX. Weiss Ratings restated a “sell (e+)” rating on shares of Jaguar Animal Health in a research note on Friday, July 17th. Wall Street Zen upgraded Jaguar Animal Health from a “sell” rating to a “hold” rating in a research report on Saturday, May 23rd. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has an average rating of “Sell”.
Get Our Latest Research Report on Jaguar Animal Health
Jaguar Animal Health Stock Performance
Jaguar Animal Health (NASDAQ:JAGX – Get Free Report) last announced its earnings results on Wednesday, May 20th. The biotechnology company reported ($13.60) EPS for the quarter, beating analysts’ consensus estimates of ($149.10) by $135.50. The business had revenue of $20.27 million during the quarter, compared to analysts’ expectations of $4.21 million.
Jaguar Animal Health Company Profile
Jaguar Animal Health, Inc is a biopharmaceutical company focused on the development and commercialization of novel therapeutics for the gastrointestinal health of food-producing animals, with an emphasis on swine and poultry. The company’s research and development efforts target common enteric disorders such as post-weaning diarrhea in pigs and clostridial overgrowth in broiler chickens, aiming to provide effective alternatives to traditional antibiotic treatments.
Jaguar Animal Health was formed in early 2019 through the acquisition of the animal health business of Aratana Therapeutics by Actinium Animal Health, followed by a corporate rebranding.
Further Reading
- Five stocks we like better than Jaguar Animal Health
- Telecom Earnings Reveal a Sector That Finally Looks Healthier
- Defense Earnings Show Readiness Now and Modernization Ahead
- Why Palantir Investors Aren’t Panicking While the Rest of AI Sells Off
- MarketBeat Week in Review – 07/20- 07/24
Receive News & Ratings for Jaguar Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.
